Skip to main content
MOVE
NASDAQ Technology

Corvex (formerly Movano) Completes Transformational AI Merger, Secures $1B Equity Facility, Faces Significant Dilution Vote

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
9
Price
$15.69
Mkt Cap
$17.734M
52W Low
$4.67
52W High
$34.87
Market data snapshot near publication time

summarizeSummary

Corvex, Inc. (formerly Movano Inc.) completed a reverse merger, pivoting to an AI cloud computing business and securing a $1 billion equity facility. The annual report details the financial struggles of the legacy healthcare business, identifies material weaknesses in internal controls, and highlights a pending shareholder vote for highly dilutive preferred stock conversions.


check_boxKey Events

  • Transformational Merger Completed

    Movano Inc. acquired Corvex Legacy Holdings, Inc. on March 19, 2026, renaming the combined entity Corvex, Inc. The company now operates two primary divisions: AI cloud computing and a legacy healthcare business.

  • Significant Equity Financing Secured

    The company established a $1.0 billion At-The-Market (ATM) equity facility with Chardan Capital Markets LLC, providing substantial capital access for future operations and growth.

  • Massive Potential Dilution Pending Shareholder Vote

    The merger involved the issuance of Series C and D Preferred Stock convertible into an aggregate of 53,778,571 common shares, contingent upon future shareholder approval. This represents an extremely high potential dilution for existing common stockholders.

  • Material Weaknesses in Internal Controls Identified

    Management identified material weaknesses in internal control over financial reporting, including an ineffective control environment, IT general controls, and process-level controls, with remediation efforts planned for 2026.


auto_awesomeAnalysis

This 10-K filing details Corvex, Inc.'s (formerly Movano Inc.) transformational reverse merger, pivoting the company to an AI cloud computing business while retaining a legacy healthcare division. The merger provides access to a substantial $1.0 billion equity facility, crucial for a company with a small market capitalization and a history of losses. However, the filing also reveals significant risks, including material weaknesses in internal controls and an auditor's continued going concern warning. Most notably, the merger involves the potential issuance of over 53 million common shares from preferred stock conversions, contingent on future shareholder approval, which represents an extremely high potential dilution for existing shareholders. Investors should carefully consider the new strategic direction and capital access against these substantial financial and governance risks.

At the time of this filing, MOVE was trading at $15.69 on NASDAQ in the Technology sector, with a market capitalization of approximately $17.7M. The 52-week trading range was $4.67 to $34.87. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MOVE - Latest Insights

MOVE
Apr 27, 2026, 6:31 PM EDT
Filing Type: 10-K/A
Importance Score:
9
MOVE
Apr 09, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
MOVE
Apr 01, 2026, 12:14 PM EDT
Filing Type: 144
Importance Score:
7
MOVE
Mar 30, 2026, 7:43 PM EDT
Filing Type: 10-K
Importance Score:
9
MOVE
Mar 19, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
10
MOVE
Mar 13, 2026, 8:57 AM EDT
Filing Type: 425
Importance Score:
7
MOVE
Feb 19, 2026, 7:30 AM EST
Filing Type: 424B7
Importance Score:
9
MOVE
Feb 12, 2026, 4:30 PM EST
Filing Type: S-1/A
Importance Score:
8
MOVE
Feb 09, 2026, 5:00 PM EST
Filing Type: S-1/A
Importance Score:
9
MOVE
Feb 04, 2026, 9:56 PM EST
Filing Type: S-4/A
Importance Score:
9